 |
ALK-Abello - SWOT Analysis |
Company Profile |
Global |
10/10/07 |
£66.00 |
| ALK-Abello SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and |
 |
E. I. duPont de Nemours and Company - SWOT Analysis |
Company Profile |
Global |
10/10/07 |
£66.00 |
| E. I. duPont de Nemours & Company SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, |
 |
Magellan Health Services - SWOT Analysis |
Company Profile |
Global |
10/10/07 |
£66.00 |
| Magellan Health Services SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and |
 |
LCA-Vision Inc. - SWOT Analysis |
Company Profile |
Global |
10/10/07 |
£66.00 |
| LCA-Vision Inc. SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, |
 |
Alliance Boots Plc - SWOT Analysis |
Company Profile |
Global |
10/10/07 |
£66.00 |
| Alliance Boots Plc SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and |
 |
Nippon Kayaku Co., Ltd. - SWOT Analysis |
Company Profile |
Global |
10/10/07 |
£66.00 |
| Nippon Kayaku Co., Ltd. SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and |
 |
Sierra Health Services - SWOT Analysis |
Company Profile |
Global |
10/10/07 |
£66.00 |
| Sierra Health Services SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and |
 |
Kindred Healthcare - SWOT Analysis |
Company Profile |
Global |
10/10/07 |
£66.00 |
| Kindred Healthcare SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and |
 |
Applera Corporation - SWOT Analysis |
Company Profile |
Global |
10/10/07 |
£66.00 |
| Applera Corporation SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and |
 |
Mylan Laboratories Inc - SWOT Analysis |
Company Profile |
Global |
10/10/07 |
£66.00 |
| Mylan Laboratories Inc SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and |
 |
Quintiles Transnational Corp. - SWOT Analysis |
Company Profile |
Global |
10/10/07 |
£66.00 |
| Quintiles Transnational Corp. SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history |
 |
Integra LifeSciences Holdings Corp - SWOT Analysis |
Company Profile |
Global |
10/10/07 |
£66.00 |
| Integra LifeSciences Holdings Corp SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, |
 |
Enzon Pharmaceuticals, Inc. - SWOT Analysis |
Company Profile |
Global |
10/10/07 |
£66.00 |
| Enzon Pharmaceuticals, Inc. SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history |
 |
Accredo Health Group, Inc - SWOT Analysis |
Company Profile |
Global |
10/10/07 |
£66.00 |
| Accredo Health Group, Inc SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and |
 |
Commercial and Pipeline Insight - Infertility - Optimizing a market bounded by social opinion and physician preference |
Market Report |
Global |
10/10/07 |
£8,000.00 |
| Introduction The market for infertility drugs is a complex and dynamic arena shaped by numerous factors such as changing social attitudes, national legislation, and prescriber preferences. Brand |
 |
Commercial Insight - Upper GI Disorders - Innovation needed to overcome generic threat |
Market Report |
Global |
08/10/07 |
£8,000.00 |
| Introduction The upper GI market, defined as gastroesophageal reflux disease (GERD), peptic ulcer disease (PUD) and dyspepsia indications, achieved sales of just over $19 billion in 2006, with |
 |
Stakeholder Insight - HIV Therapy Dynamics |
Market Report |
Global |
08/10/07 |
£8,000.00 |
| Introduction Despite several developments in efforts to tackle the spread of HIV, the total number of people living with HIV has continued to increase across the 6MM. However, significant advances |
 |
Commercial and Pipeline Insight - Allergic Rhinitis |
Market Report |
Global |
08/10/07 |
£8,000.00 |
| Introduction The allergic rhinitis market will continue to decline over the next few years, after which it will resume limited growth due to the introduction of new compounds and combination |
 |
Biotechnology - Global Industry Guide |
Market Report |
Global |
04/10/07 |
£525.00 |
| Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, textual |
 |
Generics - Global Industry Guide |
Market Report |
Global |
04/10/07 |
£525.00 |
| Generics: Global Industry Guide is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, textual analysis of |
 |
Orthopedics - Global Industry Guide |
Market Report |
Global |
04/10/07 |
£525.00 |
| Orthopedics: Global Industry Guide is an essential resource for top-level data and analysis covering the orthopedics industry. It includes detailed data on market size and segmentation, textual |
 |
Sandoz - PharmaVitae Generics Profile |
Market Report |
Global |
03/10/07 |
£2,005.00 |
| Introduction This analysis examines the historical and forecast performance for Sandoz in the generic pharmaceutical sector. The profile encompasses global company strategy, generic and biosimilar |
 |
Barr - PharmaVitae Generics Profile |
Market Report |
Global |
03/10/07 |
£2,005.00 |
| Introduction This analysis examines the historical and forecast performance for Barr in the generic pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline |
 |
Biosimilars Series - Strategic issues - Potential remains uncertain |
Market Report |
Global |
03/10/07 |
£2,005.00 |
| Introduction Significant barriers to entry into the biosimilars market exist. High up-front investment and the need for specific expertise favor big players. Understanding of the marketplace is |
 |
China Pharmaceutical Guidebook - Latest Chinese Regulations for Imported Drug Registration |
Market Report |
China |
01/10/07 |
£1,499.00 |
| China possesses one fifth of the world’s population and has one of the largest drug markets in the world. By 2006, sales on the Chinese drug market reached $12 billion dollars, an increase of 3.8 |